109 related articles for article (PubMed ID: 22509921)
1. Monoclonal antibody BP180 against bullous pemphigoid antigen-2 type XVII collagen.
Fairley JA
Hybridoma (Larchmt); 2012 Apr; 31(2):146-7. PubMed ID: 22509921
[No Abstract] [Full Text] [Related]
2. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex.
Powell AM; Sakuma-Oyama Y; Oyama N; Black MM
Clin Exp Dermatol; 2005 Nov; 30(6):682-7. PubMed ID: 16197389
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Dermatol Clin; 2011 Jul; 29(3):439-46, ix. PubMed ID: 21605809
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris.
Inokuma D; Kodama K; Natsuga K; Kasai M; Abe M; Nishie W; Abe R; Hashimoto T; Shimizu H
Br J Dermatol; 2009 Feb; 160(2):451-4. PubMed ID: 19077079
[No Abstract] [Full Text] [Related]
6. Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.
Messingham KA; Onoh A; Vanderah EM; Giudice GJ; Fairley JA
Hybridoma (Larchmt); 2012 Apr; 31(2):111-7. PubMed ID: 22509915
[TBL] [Abstract][Full Text] [Related]
7. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
9. Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.
Imanishi A; Imanishi H; Hiroyasu S; Ozawa T; Koga H; Ishii N; Kitajima Y; Hashimoto T; Tsuruta D
Med Mol Morphol; 2016 Jun; 49(2):89-97. PubMed ID: 26658728
[TBL] [Abstract][Full Text] [Related]
10. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid with IgG autoantibodies to BP180 C-terminal domain and desmocollin 3 associated with transverse colon cancer.
Yamashita H; Ansai S; Ueno T; Osada S; Kawana S; Koga H; Ishii N; Hashimoto T
Eur J Dermatol; 2015; 25(5):515-6. PubMed ID: 26693637
[No Abstract] [Full Text] [Related]
13. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.
Iwata H; Kamio N; Aoyama Y; Yamamoto Y; Hirako Y; Owaribe K; Kitajima Y
J Invest Dermatol; 2009 Apr; 129(4):919-26. PubMed ID: 19177144
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
Xu L; Olivry T; Chan LS
Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
[TBL] [Abstract][Full Text] [Related]
15. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic bullous pemphigoid: clinical disease activity correlated with enzyme-linked immunosorbent assay index for the NC16A domain of BP180.
Song HJ; Han SH; Hong WK; Lee HS; Shin JH; Choi GS
J Dermatol; 2009 Jan; 36(1):66-8. PubMed ID: 19207441
[No Abstract] [Full Text] [Related]
17. Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease.
Sitaru C
J Invest Dermatol; 2009 Apr; 129(4):822-4. PubMed ID: 19322161
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid with linear lesions and antibodies exclusively against the soluble ectodomain of BP180 (LAD-1).
Mahmoudi H; Toosi R; Kamyab K; Zillikens D; Schmidt E; Daneshpazhooh M
J Dtsch Dermatol Ges; 2019 Sep; 17(9):933-935. PubMed ID: 31353797
[No Abstract] [Full Text] [Related]
19. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
Shipman AR; Cooper S; Wojnarowska F
Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
[TBL] [Abstract][Full Text] [Related]
20. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
Yuen WY; Di Zenzo G; Jonkman MF; Pas HH
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1426-7. PubMed ID: 26334130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
